Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive Esophagitis

Clinical trial NCT07732075 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07732075
Sponsor: Onconic Therapeutics Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Maintenance of Healed Erosive Gastroesophageal Reflux Disease (ERD)

Start date: 2026-08-01
Primary completion: 2028-10-30
Enrollment: 384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.